SCHEMBL29411596

SCHEMBL29411596

O=C(NCCCc1ccc(-c2ccccc2F)cc1)c1cc(-c2ccccc2)on1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 6/20 0.76
HIF1A Q16665 2/20 0.65
HDAC6 Q9UBN7 5/20 0.56
HDAC3 O15379 3/20 0.56
HDAC1 Q13547 3/20 0.56
HDAC2 Q92769 3/20 0.56
HDAC10 Q969S8 3/20 0.56
HDAC8 Q9BY41 3/20 0.56
NPC1 O15118 1/20 0.55
LMNA P02545 1/20 0.55
TP53 P04637 1/20 0.55
HTT P42858 1/20 0.55
RAB9A P51151 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
MAPT P10636 1/20 0.54
POLB P06746 1/20 0.54
HDAC4 P56524 2/20 0.53
HDAC7 Q8WUI4 2/20 0.53
HDAC11 Q96DB2 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21045410 1.00 FAAH (0.76) FAAHHIF1AHDAC6HDAC3HDAC1
SCHEMBL21045149 0.86 LMNA (0.56) FAAHHIF1ANPC1LMNATP53
SCHEMBL29411461 0.86 LMNA (0.56) FAAHHIF1ANPC1LMNATP53
SCHEMBL17737727 0.86 FAAH (0.84) FAAHHIF1AHDAC6HDAC3HDAC1
SCHEMBL21045118 0.81 POLB (0.50) FAAHHIF1ANPC1RAB9ASMN1; SMN2
SCHEMBL29411496 0.81 POLB (0.50) FAAHHIF1ANPC1RAB9ASMN1; SMN2
SCHEMBL16486106 0.79 FAAH (0.95) FAAHHIF1AHDAC6HDAC3HDAC1
SCHEMBL21045136 0.79 HDAC3 (0.50) FAAHHIF1AHDAC3HDAC1NPC1
SCHEMBL29411455 0.79 HDAC3 (0.50) FAAHHIF1AHDAC3HDAC1NPC1
SCHEMBL17652827 0.79 FAAH (0.84) FAAHHIF1AHDAC6HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250188035-A1 TUBULIN INHIBITORS LIN BIOSCIENCE LLC (US) 2025-06-12 US disclosed
US-12247010-B2 Tubulin inhibitors LIN BIOSCIENCE INC. (TW) 2025-03-11 US disclosed
US-20220089539-A1 TUBULIN INHIBITORS LIN BIOSCIENCE INC. (TW) 2022-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220089539-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB FAAH 4071/4885HIF1A 3747/4885HDAC6 30/4885
US-12247010-B2 Tubulin inhibitors TUBB3, TUBB1, TUBB FAAH 4071/4885HIF1A 3747/4885HDAC6 30/4885
US-20250188035-A1 TUBULIN INHIBITORS TUBB3, TUBB1, TUBB FAAH 4071/4885HIF1A 3747/4885HDAC6 30/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.